Trials / Completed
CompletedNCT00552175
A Study for the Treatment of Diabetic Peripheral Neuropathic Pain
A Superiority Study of LY248686 Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 339 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 20 Years – 79 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to determine if duloxetine can help patients with painful diabetic neuropathy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine hydrochloride - 40 mg | duloxetine 40 mg taken orally every day |
| DRUG | placebo | placebo taken orally every day |
| DRUG | Duloxetine hydrochloride - 60 mg | duloxetine 60 mg taken orally every day |
Timeline
- Start date
- 2007-11-01
- Primary completion
- 2009-03-01
- Completion
- 2009-03-01
- First posted
- 2007-11-01
- Last updated
- 2010-04-13
- Results posted
- 2010-04-13
Locations
25 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00552175. Inclusion in this directory is not an endorsement.